Vanguard Group
CELU icon

Vanguard Group’s Celularity CELU Stock Holding History

Vanguard Group’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$751K Hold
676,650
– – ﹤0.01% 3846
2025
Q3 		$1.4M Buy
676,650
+176,518
+35% +$494K ﹤0.01% 3684
2025
Q2 		$980K Hold
500,132
– – ﹤0.01% 3749
2025
Q1 		$865K Hold
500,132
– – ﹤0.01% 3759
2024
Q4 		$1.04M Hold
500,132
– – ﹤0.01% 3751
2024
Q3 		$1.49M Hold
500,132
– – ﹤0.01% 3650
2024
Q2 		$1.57M Buy
500,132
+115,214
+30% +$400K ﹤0.01% 3642
2024
Q1 		$2.01M Buy
384,918
+11,597
+3% +$47.7K ﹤0.01% 3591
2023
Q4 		$924K Buy
373,321
+25,826
+7% +$56.1K ﹤0.01% 3855
2023
Q3 		$772K Buy
347,495
+88,866
+34% +$319K ﹤0.01% 3923
2023
Q2 		$1.38M Sell
258,629
-38,748
-13% -$248K ﹤0.01% 3798
2023
Q1 		$1.84M Sell
297,377
-936
-0.3% -$7.53K ﹤0.01% 3706
2022
Q4 		$3.85M Sell
298,313
-267
-0.1% -$4.92K ﹤0.01% 3428
2022
Q3 		$6.9M Buy
298,580
+117,290
+65% +$3.56M ﹤0.01% 3136
2022
Q2 		$6.16M Buy
+181,290
New +$14.7M ﹤0.01% 3261

Other funds holding CELU

CVSC
C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $15.5B AUM 18.35% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $716M AUM 21.09% 1-Year Est. Return

Vanguard Group's CELU Position: Q4 2025 in Review

Vanguard Group held its Celularity (CELU) position steady in Q4 2025 at 676,650 shares worth $751K. The position accounts for ﹤0.01% of the portfolio, ranked #3846.

Vanguard Group first reported a position in CELU in Q2 2022 and has held it in 15 quarters since. The position peaked at $6.9M in Q3 2022. 36 funds tracked by Wall St. Rank hold CELU as of Q4 2025.

  • Vanguard Group held 676,650 shares of Celularity worth $751K as of Q4 2025.
  • Vanguard Group left its Celularity share count unchanged in Q4 2025.
  • Celularity made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3846 holding.
  • Vanguard Group first reported a position in Celularity in Q2 2022 and has held it in 15 quarters since.
  • Vanguard Group's Celularity position peaked at $6.9M in Q3 2022.
  • 36 funds tracked by Wall St. Rank held Celularity as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.